透导管中管边缘到边缘修复的指示正在变化
Mony Shuvy1, Francesco Maisano2
1Jesselson Integrated Heart Centre, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel.
概括
透导管美肌边缘修复 (TEER) 为高风险患者提供了对美肌吐 (MR) 的安全有效治疗方法. 这篇评论探讨了TEER的研究.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 透导管关节端到端修复 (TEER) 是对关节反 (MR) 的一个成熟的治疗方法.
- 在不同的解剖学中,TEER在初级和二级MR中都表现出有效性.
- 它的微创性和安全性对高风险患者有利.
研究的目的:
- 审查TEER的使用超出其公认的适用性.
- 检查TEER在不同患者群体中的结果和局限性.
- 突出TEER在特定高风险场景中的潜力,这些场景通常不包括在主要试验中.
主要方法:
- 关于TEER手术和干预研究的文献综述.
- 对患有特定疾病的患者群体的结局分析,如后MI MR,高性阻塞性心肌病和外科后MR.
- 检查TEER在超出标准指示的场景中的应用.
主要成果:
- 在各种解剖学方面,TEER已经取得了程序性成功.
- 随着TEER的使用,观察到立即的血液动力学改善.
- 有证据表明,通过降低高风险人群中的MR来改善潜在的临床效果.
结论:
- 对于那些不适合进行手术的高风险患者来说,TEER是有前途的.
- 需要进一步的研究来评估TEER在更广泛的临床场景中的好处.
- 扩大TEER的指示可能会改善服务不足的患者群体的结果.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis II: Clinical features and Diagnostic Tests
557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535


